123 related articles for article (PubMed ID: 31649876)
1. Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014.
Leroy R; De Gendt C; Stordeur S; Schillemans V; Verleye L; Silversmit G; Van Eycken E; Savoye I; Grégoire V; Nuyts S; Vermorken J
Front Oncol; 2019; 9():1006. PubMed ID: 31649876
[No Abstract] [Full Text] [Related]
2. Quality of care and variability in lung cancer management across Belgian hospitals: a population-based study using routinely available data.
Vrijens F; De Gendt C; Verleye L; Robays J; Schillemans V; Camberlin C; Stordeur S; Dubois C; Van Eycken E; Wauters I; Van Meerbeeck JP
Int J Qual Health Care; 2018 May; 30(4):306-312. PubMed ID: 29506181
[TBL] [Abstract][Full Text] [Related]
3. Improved survival in patients with head and neck cancer treated in higher volume centres: A population-based study in Belgium.
Leroy R; Silversmit G; Stordeur S; De Gendt C; Verleye L; Schillemans V; Savoye I; Van Eycken L; Deron P; Hamoir M; Vermorken J; Grégoire V; Nuyts S
Eur J Cancer; 2020 May; 130():81-91. PubMed ID: 32179449
[TBL] [Abstract][Full Text] [Related]
4. Patterns and quality of care for head and neck cancer in Belgium: A population-based study.
Verleye L; De Gendt C; Leroy R; Stordeur S; Schillemans V; Savoye I; Silversmit G; Van Eycken L; Daisne JF; Nuyts S; Vermorken J; Grégoire V
Eur J Cancer Care (Engl); 2021 Sep; 30(5):e13454. PubMed ID: 33890328
[TBL] [Abstract][Full Text] [Related]
5. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
[TBL] [Abstract][Full Text] [Related]
6. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
[TBL] [Abstract][Full Text] [Related]
7. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis.
Cacicedo J; Fernandez I; Del Hoyo O; Dolado A; Gómez-Suarez J; Hortelano E; Sancho A; Pijoan JI; Alvarez J; Espinosa JM; Gaafar A; Bilbao P
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1378-89. PubMed ID: 25952280
[TBL] [Abstract][Full Text] [Related]
8. A PET/CT-Based Strategy Is a Stronger Predictor of Survival Than a Standard Imaging Strategy in Patients with Head and Neck Squamous Cell Carcinoma.
Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2018 Apr; 59(4):575-581. PubMed ID: 28864630
[TBL] [Abstract][Full Text] [Related]
9. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
[TBL] [Abstract][Full Text] [Related]
10. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
Lonneux M; Hamoir M; Reychler H; Maingon P; Duvillard C; Calais G; Bridji B; Digue L; Toubeau M; Grégoire V
J Clin Oncol; 2010 Mar; 28(7):1190-5. PubMed ID: 20124179
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
13.
Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
[TBL] [Abstract][Full Text] [Related]
14.
van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
[TBL] [Abstract][Full Text] [Related]
15. Integration of 18-FDG PET/CT in the Initial Work-Up to Stage Head and Neck Cancer: Prognostic Significance and Impact on Therapeutic Decision Making.
Leclere JC; Delcroix O; Rousset J; Valette G; Robin P; Guezennec C; Le Pennec R; Gujral DM; Abgral M; Ollivier L; Marianowski R; Salaun PY; Schick U; Abgral R
Front Med (Lausanne); 2020; 7():273. PubMed ID: 32714934
[No Abstract] [Full Text] [Related]
16. Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Goel R; Moore W; Sumer B; Khan S; Sher D; Subramaniam RM
AJR Am J Roentgenol; 2017 Aug; 209(2):289-303. PubMed ID: 28731808
[TBL] [Abstract][Full Text] [Related]
17. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
[TBL] [Abstract][Full Text] [Related]
18. Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma.
Rohde M; Nielsen AL; Johansen J; Sørensen JA; Diaz A; Pareek M; Asmussen JT; Gerke O; Thomassen A; Gyldenkerne N; Døssing H; Bjørndal K; Høilund-Carlsen PF; Godballe C
Oral Oncol; 2019 Jul; 94():1-7. PubMed ID: 31178202
[TBL] [Abstract][Full Text] [Related]
19. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
20. Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma.
Rohde M; Nielsen AL; Johansen J; Sørensen JA; Diaz A; Asmussen JT; Gerke O; Thomassen A; Gyldenkerne N; Døssing H; Bjørndal K; Høilund-Carlsen PF; Godballe C
Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):613-621. PubMed ID: 29124279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
